BroadOak Partners advises Caliper Life Sciences, Inc., a leading provider of tools and services for drug discovery and life sciences research, on the sale of Xenogen Biosciences Corporation, a subsidiary which provides in-vivo preclinical CRO services, to Taconic Farms, Inc.
BroadOak Partners advises Alpha Innotech Corp., a leading provider of imaging systems to the life sciences industry, on the sale of the Company to Cell Biosciences, Inc.
BroadOak Partners advises Orion Genomics, LLC, a privately held biotechnology company developing epigenetic research tools and molecular diagnostic products for personalized medicine, on the discovery collaboration and license agreement to advance personalized diagnostics with Novartis AG.
BroadOak Partners advises Clinical Data, Inc., a biotechnology company developing early and late stage therapeutics, on the sale of certain non-core assets to Intrexon Corporation.
BroadOak Partners provides financial advice to Turner BioSystems, Inc., a provider of microplate and single tube reader instruments for the life science industry, on its sale to Promega Corp.
BroadOak Partners advises Assay Designs, Inc., a provider of research product kits and reagents to the life science’s industry, on the sale of the Company to Enzo Biochem, Inc.